InVivo Therapeutics Holdings Corp (NVIV)

Name: InVivo Therapeutics Holdings Corp (NVIV) Share Price Today, Stock Analysis, Annual Report | Value Research
Brand: InVivo Therapeutics Holdings Corp (NVIV)

Stock Card

$0.26

$-0.06 (-18.93%)

As on 08-Mar-2024 09:30EDT

Market cap

$1 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

P/B Ratio

0.1

Div. Yield

0 %

InVivo Therapeutics Holdings (NVIV) Share Price

Compare

High: Low: Return:

Price P/E Ratio P/B Ratio

Stock Range

Today’s Range

Low: 0.25 High: 0.30

52 Week Range

Low: -- High: --

Liquidity

Low Moderate High

Fundamentals

Net Profit (TTM)

$-9 Mln
ROE

-1 %
ROCE

-- %
Industry P/E

43.09
EV/EBITDA

0.8
Debt to Equity

0
Book Value

$--
EPS

$-3.7
Face value

--
Shares outstanding

3,105,450

10 Years Aggregate

CFO

$-129.66 Mln

EBITDA

$-125.58 Mln

Net Profit

$-198.78 Mln

Company	YTD	1 Month	3 Months	1 Year	3 Years	5 Years	10 Years
InVivo Therapeutics Holdings (NVIV)	-64.4	-59.6	-67.5	-87.4	-78.8	-81.2	-74.0
BSE Sensex^*	-11.7	-4.8	1.1	-8.2	3.9	5.1	10.0
S&P Small-Cap 600^#	-5.8	-5.3	-13.7	-6.3	5.3	3.0	5.5

As on 08-Mar-2024 | *As on 11-Sep-2026 | #As on 26-Oct-2023

Company	2023	2021	2020	2019	2018	2017
InVivo Therapeutics Holdings (NVIV)	-68.9	-43.2	-88.0	-85.1	-92.0	-81.7
S&P Small-Cap 600	13.9	25.3	9.6	20.9	-9.7	11.7
BSE Sensex	18.7	22.0	15.8	14.4	5.9	27.9

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details

Key Ratios

View Details

Shareholding Pattern

View Details

About InVivo Therapeutics Holdings (NVIV)

InVivo Therapeutics Holdings Corp. operates as a research and clinical-stage biomaterials and biotechnology company in the United States. The company engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal... cord injuries (SCI). It is developing a Neuro-Spinal Scaffold implant comprise of biocompatible and bioresorbable polymers, which includes Poly lactic-co-glycolic acid, a polymer which is widely used in resorbable sutures and provides the biocompatible support for Neuro-Spinal Scaffold implant; and Poly-L-Lysine, a positively charged polymer used to coat surfaces to promote cellular attachment. The company was incorporated in 2003 and is headquartered in Cambridge, Massachusetts. On February 1, 2024, InVivo Therapeutics Holdings Corp. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware. It is in joint administration with InVivo Therapeutics Corporation. Read more

President, CEO, Chief Medical Officer & Director

Dr. Richard M. Toselli M.D.
President, CEO, Chief Medical Officer & Director

Dr. Richard M. Toselli M.D.
Headquarters

Cambridge, MA
Website

https://www.invivotherapeutics.com

FAQs for InVivo Therapeutics Holdings (NVIV)

What is the current share price of InVivo Therapeutics Holdings Corp (NVIV) Today?

The share price of InVivo Therapeutics Holdings Corp (NVIV) is $0.26 (NASDAQ) as of 08-Mar-2024 09:30 EDT. InVivo Therapeutics Holdings Corp (NVIV) has given a return of -78.79% in the last 3 years.

What is the current PB & PE ratio of InVivo Therapeutics Holdings Corp (NVIV)?

Since, TTM earnings of InVivo Therapeutics Holdings Corp (NVIV) is negative, P/E ratio is not available.
The P/B ratio of InVivo Therapeutics Holdings Corp (NVIV) is 0.10 times as on 08-Mar-2024, a 97 discount to its peers’ median range of 3.60 times.

PE & PB ratio at the end of financial year.

Year	P/E Ratio	P/B Ratio
2022	-0.35	0.23
2021	-0.06	0.03
2020	-0.02	0.01
2019	0.00	0.00
2018	0.00	0.00

What is the 52 Week High and Low of InVivo Therapeutics Holdings Corp (NVIV)?

The 52-week high and low of InVivo Therapeutics Holdings Corp (NVIV) are Rs -- and Rs -- as of 13-Sep-2026.

What is the market cap of InVivo Therapeutics Holdings Corp (NVIV)?

InVivo Therapeutics Holdings Corp (NVIV) has a market capitalisation of $ 1 Mln as on 08-Mar-2024. As per SEBI classification, it is a Small Cap company.

Should I invest in InVivo Therapeutics Holdings Corp (NVIV)?

Before investing in InVivo Therapeutics Holdings Corp (NVIV), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.

Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.